HAROLD SHINE to Combined Modality Therapy
This is a "connection" page, showing publications HAROLD SHINE has written about Combined Modality Therapy.
Connection Strength
0.008
-
Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors. Mol Ther. 2000 Feb; 1(2):195-203.
Score: 0.008